| Nombre | Nivel | Co-inversiones | Socios principales | Área de enfoque | Etapa preferida | Países inversores | Promedio rondas |
|---|---|---|---|---|---|---|---|
 Solana Ventures | 2 | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | |
 Ryze Labs (Sino Global Capital) | 2 | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | |
 SkyVision Capital | 3 | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | |
 Lemniscap | 3 | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | |
 Zokyo | 3 | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | |
 Alameda Research | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Serum | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Chris McCann | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Switchboard | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Brandon Potts | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Atrix | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Dermot McGrath | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Ryon Nixon | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M | ||
 Steve Harvey | 1 | #Focus Area+3 | Types +3 | #Country | $10-20M |
1 - 14 de 14
Mostrar filas
20
